Rockwell Medical Inc
RMTI1.040USD
0.000
收盘 11/05, 16:00（美东）报价延迟15分钟
35.81M总市值
亏损市盈率 TTM
关于 Rockwell Medical Inc 公司
Rockwell Medical, Inc. 是一家医疗保健公司。该公司为世界各地的透析提供商开发、制造、销售和分销一系列血液透析产品。该公司在血液透析市场开展业务，涉及制造、销售和分销血液透析产品给血液透析诊所，包括透析过程中使用的药品、透析浓缩液、透析套件和其他辅助产品。该公司是透析诊所维持生命的血液透析浓缩液产品的供应商。其血液透析浓缩液产品用于通过清除毒素和平衡透析患者血液中的电解质来维持患者的生命。该公司在密歇根州、南卡罗来纳州和德克萨斯州的工厂生产血液透析浓缩液，并在爱荷华州的工厂生产干酸浓缩液混合器。
Rockwell Medical Inc简介
公司代码RMTI
公司名称Rockwell Medical Inc
上市日期Jan 27, 1998
CEODr. Mark Strobeck, Ph.D.
员工数量244
证券类型Ordinary Share
年结日Jan 27
公司地址30142 Wixom Road
城市WIXOM
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编48393
电话18004493353
网址https://www.rockwellmed.com/
公司代码RMTI
上市日期Jan 27, 1998
CEODr. Mark Strobeck, Ph.D.
Rockwell Medical Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+52.38%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Director
Independent Director
142.06K
+54.31%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
105.95K
-0.83%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+52.38%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Director
Independent Director
142.06K
+54.31%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
收入明细
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%
地区USD
名称
营收
占比
United States
14.19M
0.00%
Rest of World
1.88M
0.00%
业务
地区
业务USD
名称
营收
占比
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%
股东统计
更新时间: 10月14日 周二
更新时间: 10月14日 周二
持股股东
股东类型
持股股东
持股股东
占比
Irrevocable Larson Family Investment Trust
10.33%
Armistice Capital LLC
6.24%
The Vanguard Group, Inc.
3.50%
Renaissance Technologies LLC
1.57%
Geode Capital Management, L.L.C.
0.93%
其他
77.42%
持股股东
持股股东
占比
Irrevocable Larson Family Investment Trust
10.33%
Armistice Capital LLC
6.24%
The Vanguard Group, Inc.
3.50%
Renaissance Technologies LLC
1.57%
Geode Capital Management, L.L.C.
0.93%
其他
77.42%
股东类型
持股股东
占比
Corporation
10.33%
Hedge Fund
8.13%
Investment Advisor
6.31%
Individual Investor
4.74%
Investment Advisor/Hedge Fund
2.66%
Research Firm
0.10%
其他
67.73%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
98
5.92M
17.19%
-2.11M
2025Q2
119
12.15M
35.56%
-1.45M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
2023Q3
122
6.04M
24.13%
+2.56M
2023Q2
133
3.92M
24.44%
+947.21K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Irrevocable Larson Family Investment Trust
3.56M
10.33%
+87.50K
+2.52%
Apr 11, 2025
Armistice Capital LLC
2.15M
6.24%
-216.67K
-9.16%
Jun 30, 2025
The Vanguard Group, Inc.
1.21M
3.5%
--
--
Jun 30, 2025
Renaissance Technologies LLC
541.75K
1.57%
+88.75K
+19.59%
Jun 30, 2025
Geode Capital Management, L.L.C.
320.67K
0.93%
-3.87K
-1.19%
Jun 30, 2025
GlobeFlex Capital, L.P.
312.06K
0.91%
-431.20K
-58.02%
Jun 30, 2025
Strobeck (Mark)
290.62K
0.84%
-6.93K
-2.33%
Jul 01, 2025
BlackRock Institutional Trust Company, N.A.
217.66K
0.63%
+1.98K
+0.92%
Jun 30, 2025
Marshall Wace LLP
173.78K
0.5%
-159.82K
-47.91%
Jun 30, 2025
Ravich (Mark H)
151.10K
0.44%
+50.00K
+49.45%
May 20, 2025
查看更多
持股ETF
更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
占比0.01%
Dimensional US Core Equity 1 ETF
占比0%
DFA Dimensional US Sustainability Core 1 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
公告日期
类型
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
